Structural insights for 3H-1,-2,-4 triazolinones as angiotensin II receptor antagonists using QSAR techniques

被引:5
作者
Parate, Anupama [1 ]
Chaturvedi, S. C. [2 ]
机构
[1] Devi Ahilya Vishwavidylaya, Sch Pharm, Indore 452017, Madhya Pradesh, India
[2] IPS Acad, Coll Pharm, Indore 452017, Madhya Pradesh, India
关键词
Angiotensin II receptor antagonists; Antihypertensive; Losartan; QSAR; Triazolinones; NONPEPTIDE ANTAGONISTS; BIOLOGICAL-ACTIVITY; POTENT; AT(1); SERIES;
D O I
10.1007/s00044-009-9197-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3H-1, -2, -4 triazolinone aryl and nonaryl substituents were subjected to QSAR analysis. Different statistically significant models were obtained, from which the most robust models for QSAR were obtained with r (2) = 0.7968 and q (2) = 0.7164 in model 1 for aryl triazolinones, and r (2) = 0.7499 and q (2) = 0.6290 for nonaryl triazolinones. The physicochemical descriptor HDonorCount and alignment-independent descriptors T_2_N_6, T_2_Cl_6, and T_2_N_4 were found to show significant correlation with biologic activity in aryl triazolinones. PolarSurfaceAreaExcludingPandS, HydrogenCount, and 6ChainCount were significant receptors in the case of nonaryl triazolinones.
引用
收藏
页码:375 / 391
页数:17
相关论文
共 25 条
[1]   Synthesis and structure-activity relationship of a new series of potent AT(1) selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles [J].
Almansa, C ;
Gomez, LA ;
Cavalcanti, FL ;
deArriba, AF ;
GarciaRafanell, J ;
Forn, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) :547-558
[2]  
BALASUBRAMANIAN N, 2007, ARKIVOC, V1, P189
[3]   A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists [J].
Belvisi, L ;
Bravi, G ;
Catalano, G ;
Mabilia, M ;
Salimbeni, A ;
Scolastico, C .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1996, 10 (06) :567-582
[4]   A NEW SERIES OF IMIDAZOLONES - HIGHLY SPECIFIC AND POTENT NONPEPTIDE AT(1) ANGIOTENSIN-II RECEPTOR ANTAGONISTS [J].
BERNHART, CA ;
PERREAUT, PM ;
FERRARI, BP ;
MUNEAUX, YA ;
ASSENS, JLA ;
CLEMENT, J ;
HAUDRICOURT, F ;
MUNEAUX, CF ;
TAILLADES, JE ;
VIGNAL, MA ;
GOUGAT, J ;
GUIRAUDOU, PR ;
LACOUR, CA ;
ROCCON, A ;
CAZAUBON, CF ;
BRELIERE, JC ;
LEFUR, G ;
NISATO, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) :3371-3380
[5]   VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES [J].
BUHLMAYER, P ;
FURET, P ;
CRISCIONE, L ;
DEGASPARO, M ;
WHITEBREAD, S ;
SCHMIDLIN, T ;
LATTMANN, R ;
WOOD, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) :29-34
[6]   TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .1. SYNTHESIS AND EVALUATION OF POTENT 2,4,5-TRISUBSTITUTED TRIAZOLINONES [J].
CHANG, LL ;
ASHTON, WT ;
FLANAGAN, KL ;
STRELITZ, RA ;
MACCOSS, M ;
GREENLEE, WJ ;
CHANG, RSL ;
LOTTI, VJ ;
FAUST, KA ;
CHEN, TB ;
BUNTING, P ;
ZINGARO, GJ ;
KIVLIGHN, SD ;
SIEGL, PKS .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (17) :2558-2568
[7]   A 3D-QSAR of angiotensin II (AT1) receptor antagonists based on receptor surface analysis [J].
Datar, PA ;
Desai, PV ;
Coutinho, EC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (01) :210-220
[8]  
DATAR PA, 2004, LETT DRUG DES DISCOV, V1, P115
[9]   PYRIDO[2,3-D]PYRIMIDINE ANGIOTENSIN-II ANTAGONISTS [J].
ELLINGBOE, JW ;
ANTANE, M ;
NGUYEN, TT ;
COLLINI, MD ;
ANTANE, S ;
BENDER, R ;
HARTUPEE, D ;
WHITE, V ;
MCCALLUM, J ;
PARK, CH ;
RUSSO, A ;
OSLER, MB ;
WOJDAN, A ;
DINISH, J ;
HO, DM ;
BAGLI, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (04) :542-550
[10]   BROMOBENZOFURAN-BASED NONPEPTIDE ANTAGONISTS OF ANGIOTENSIN-II - GR138950, A POTENT ANTIHYPERTENSIVE AGENT WITH HIGH ORAL BIOAVAILABILITY [J].
JUDD, DB ;
DOWLE, MD ;
MIDDLEMISS, D ;
SCOPES, DIC ;
ROSS, BC ;
JACK, TI ;
PASS, M ;
TRANQUILLINI, E ;
HOBSON, JE ;
PANCHAL, TA ;
STUART, PG ;
PATON, JMS ;
HUBBARD, T ;
HILDITCH, A ;
DREW, GM ;
ROBERTSON, MJ ;
CLARK, KL ;
TRAVERS, A ;
HUNT, AAE ;
POLLEY, J ;
EDDERSHAW, PJ ;
BAYLISS, MK ;
MANCHEE, GR ;
DONNELLY, MD ;
WALKER, DG ;
RICHARDS, SA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (19) :3108-3120